A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/1999
11/02/1999	US5977098 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
11/02/1999	US5977071 Complexes; antidiabetic agent
11/02/1999	US5976849 Human E3 ubiquitin protein ligase
11/02/1999	US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999	US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999	US5976597 Basic protein composition, basic peptide composition and application thereof
11/02/1999	US5976550 Dietary food supplement
11/02/1999	US5976548 Nutritional supplement composition and use
11/02/1999	CA2053911C Recombinant antibody-toxin fusion protein
10/1999
10/28/1999	WO1999054469A1 B-cell growth factor related protein
10/28/1999	WO1999054443A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep
10/28/1999	WO1999054408A1 Trans-xanthophyll ester concentrates of enhanced purity and methods of making same
10/28/1999	WO1999054351A1 Edg family gene, human h218
10/28/1999	WO1999053953A2 Methods and products related to metabolic interactions in disease
10/28/1999	WO1999053936A1 Hypoglycemic agents
10/28/1999	WO1999053934A1 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis
10/28/1999	WO1999053921A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
10/28/1999	WO1999042127A3 Receptor derived peptides as modulators of receptor activity
10/28/1999	WO1999042089A9 Use of thiadiazolo[4,3-a]pyridine derivatives
10/28/1999	WO1999040946A3 Methods and compositions for modulating leptin activity
10/28/1999	WO1999021540B1 Method of reducing craving in mammals
10/28/1999	WO1999004773A9 Method for inhibiting bone resorption
10/28/1999	DE19818563A1 Reducing appetite and body weight, especially for treating obesity, by administration of alpha-lipoic acid
10/28/1999	CA2328331A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
10/28/1999	CA2325871A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep
10/28/1999	CA2325848A1 B-cell growth factor related protein
10/28/1999	CA2324995A1 Methods and products related to metabolic interactions in disease
10/27/1999	EP0952154A2 N-acyl and N-aroyl aralkyl amides
10/27/1999	EP0951915A2 System and method for providing a sterile medical solution containing glucose orglucose-like compounds
10/27/1999	EP0951911A2 Method for administering aspb28-human insulin
10/27/1999	EP0951910A2 Method for administering monomeric insulin analogs
10/27/1999	EP0951907A1 Use of moxonidine as a thermogenesis stimulating agent
10/27/1999	EP0951842A2 Infant formula
10/27/1999	EP0951542A2 Secreted proteins and polynucleotides encoding them
10/27/1999	CN1233254A Purine L-nucleosides, analogs and uses thereof
10/27/1999	CN1233241A Propionic acid derivatives and applications thereof
10/27/1999	CN1233182A Citrus peel extract as 3-hydroxy-3-methyl glutaryl-CoA (HMG-CoA) reductase inhibitor
10/27/1999	CN1233175A Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
10/27/1999	CN1233174A Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
10/27/1999	CN1232866A Gallnut oil and its extraction process and application in pharmacy
10/27/1999	CN1232693A Health beverage for preventing and curing hypertension and hyperlipemia
10/27/1999	CN1045964C Heterocyclic compounds and their preparation and use
10/26/1999	US5973007 Use of inhibitors of retinoic acid activity for wound healing
10/26/1999	US5972989 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/26/1999	US5972970 Oxazolidinedione derivatives, their production and use
10/26/1999	US5972959 Oxime derivatives, their preparation and their therapeutic use
10/26/1999	US5972944 Use of thiazolidinedione derivatives in the treatment of anovulation, hyperandrogenism and hirsutism
10/26/1999	US5972940 Arginine analogues having nitric oxide synthase inhibitor activity
10/26/1999	US5972935 Psychological disordrs, nervous system disorders, parkinson's disorder
10/26/1999	US5972925 1-(3-(2-chloro-12h-dibenzo(d,g)(1,3,6)dioxazocin-12-yl)-1-prop yl)-3-piperidinecarboxylic acid, for example; treating neurogenic pain (in which c-fibers play a role) or inflammation such as migraine or diabetic neuropathy
10/26/1999	US5972921 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men
10/26/1999	US5972902 DNA encoding human IL-6 receptor antagonist and protein encoded thereby
10/26/1999	US5972899 Apoptosis induced by Shigella IpaB
10/26/1999	US5972894 Peptides having potassium channel opener activity
10/26/1999	US5972680 An aminopeptidase which is involved in insulin regulation.
10/26/1999	US5972664 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
10/26/1999	US5972652 Polynucleotides encoding secreted proteins
10/26/1999	US5972636 ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
10/26/1999	US5972382 Use of piperine as a bioavailability enhancer
10/26/1999	US5972342 Antidiabetic agents
10/26/1999	US5972333 Synthetic mammalian sulphamidase and genetic sequences encoding same
10/26/1999	CA1340804C Mixed compositions for treating hypercholesterolemia
10/26/1999	CA1340798C Disubstituted pyridines
10/21/1999	WO1999053052A2 Srebp-2-deficient cell lines
10/21/1999	WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999	WO1999052907A1 Azabicyclic 5ht1 receptor ligands
10/21/1999	WO1999052901A1 Paroxetine maleate
10/21/1999	WO1999052898A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
10/21/1999	WO1999052896A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999	WO1999052889A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
10/21/1999	WO1999052876A1 Azacycloalkane derivatives, preparation and therapeutic application
10/21/1999	WO1999052862A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
10/21/1999	WO1999052536A1 Use of at least a plant extract of the compositae family, such as the genus bellis
10/21/1999	WO1999052514A2 Pharmaceutical composition and combination preparation for immunosuppressive therapy
10/21/1999	WO1999052493A2 Compounds that inhibit the binding of integrins to their receptors
10/21/1999	WO1999052363A1 Method of regulating appetite and metabolism
10/21/1999	WO1999038501A9 Method of regulating glucose metabolism, and reagents related thereto
10/21/1999	WO1999037623A3 Sulphonamide derivatives for treatment of cns disorders
10/21/1999	CA2328729A1 Method of regulating appetite and metabolism
10/21/1999	CA2327782A1 Azabicyclic 5ht1 receptor ligands
10/21/1999	CA2327450A1 Paroxetine maleate
10/21/1999	CA2327431A1 Pharmaceutical composition
10/21/1999	CA2326665A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/20/1999	EP0950416A1 Preventive and/or therapeutic agent for cachexia
10/20/1999	EP0950411A1 Process of manufacturing an extract from the Copalchi stem barks and the use of neoflavonoids for the treatment of diabetes
10/20/1999	EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999	EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999	EP0949928A1 Androgenic and bisphosphonic agents coadministered to treat diseases
10/20/1999	EP0949919A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions
10/20/1999	CN1232499A Human growth gene and short stature gene region
10/20/1999	CN1232470A GLP-1 derivs.
10/20/1999	CN1232451A Substd. cyclic amine metalloprotease inhibitors
10/20/1999	CN1232394A Solid oral dosage forms of valsartan
10/20/1999	CN1232038A New peptide compounds, process for their preparation and pharmaceutical compositions containing them
10/20/1999	CN1231914A Hypoglycemic plaster
10/20/1999	CN1045776C Thiazolidines and oxazolidines substd. by pyridine ring and their use as hypoglycemic agents
10/19/1999	US5969184 Amide compounds
10/19/1999	US5969156 Crystalline [R- (R,R)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
10/19/1999	US5969125 Polynucleotideds that encode polypeptides that can be used to generate antibodies to prevent, treat, and reduce effects of disease
10/19/1999	US5969095 Analogs of parathyroid hormone

1 ... 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 ... 1298